{"database": "lobbying", "table": "lobbying_activities", "rows": [[2308395, "73871046-3623-437c-af22-94df4242dd84", "Q2", "BALCH & BINGHAM, LLP", 5197, "TRANSCENDENCE, INC.", 2019, "second_quarter", "MED", "New medical innovations for improved treatment.", null, null, null, 0, 0, "2019-07-17T17:03:26.177000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2308395"], "units": {}, "query_ms": 0.34586095716804266, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}